MA34319B1 - Caséinesuccinylate de fer (iii) et son procédé de préparation - Google Patents

Caséinesuccinylate de fer (iii) et son procédé de préparation

Info

Publication number
MA34319B1
MA34319B1 MA35466A MA35466A MA34319B1 MA 34319 B1 MA34319 B1 MA 34319B1 MA 35466 A MA35466 A MA 35466A MA 35466 A MA35466 A MA 35466A MA 34319 B1 MA34319 B1 MA 34319B1
Authority
MA
Morocco
Prior art keywords
iron
iii
preparation
caseinsuccinylate
caseinuccinylate
Prior art date
Application number
MA35466A
Other languages
English (en)
Inventor
Andrea Stevenazzi
Ferra Lorenzo De
Barbara Pinto
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of MA34319B1 publication Critical patent/MA34319B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne un caséinesuccinylate de fer (III) caractérisé par une teneur en fer comprise entre 4,5 et 7 % en poids, et par une solubilité dans l'eau supérieure à environ 92 %. La présente invention concerne, en outre, un procédé de préparation d'un caséinesuccinylate de fer (III).
MA35466A 2010-06-30 2010-06-30 Caséinesuccinylate de fer (iii) et son procédé de préparation MA34319B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2010/000287 WO2012001712A1 (fr) 2010-06-30 2010-06-30 Caséinesuccinylate de fer (iii) et son procédé de préparation

Publications (1)

Publication Number Publication Date
MA34319B1 true MA34319B1 (fr) 2013-06-01

Family

ID=43302532

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35466A MA34319B1 (fr) 2010-06-30 2010-06-30 Caséinesuccinylate de fer (iii) et son procédé de préparation

Country Status (20)

Country Link
US (1) US20130102529A1 (fr)
EP (1) EP2588488B1 (fr)
KR (1) KR101701830B1 (fr)
CN (2) CN107090011A (fr)
AR (1) AR122394A2 (fr)
BR (1) BR112012032364B1 (fr)
CY (1) CY1119054T1 (fr)
DK (1) DK2588488T3 (fr)
ES (1) ES2628306T3 (fr)
HR (1) HRP20170541T1 (fr)
HU (1) HUE032746T2 (fr)
LT (1) LT2588488T (fr)
MA (1) MA34319B1 (fr)
MX (1) MX346317B (fr)
PL (1) PL2588488T3 (fr)
PT (1) PT2588488T (fr)
RS (1) RS55978B1 (fr)
RU (1) RU2533826C2 (fr)
SI (1) SI2588488T1 (fr)
WO (1) WO2012001712A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836419B (zh) * 2012-09-25 2014-06-25 济川药业集团有限公司 一种蛋白琥珀酸铁口服溶液及其制备方法
CN108498454B (zh) * 2018-04-03 2020-11-06 济川药业集团有限公司 一种蛋白琥珀酸铁口服液及其制备方法
CN111000977A (zh) * 2019-03-22 2020-04-14 江苏中天药业有限公司 一种蛋白琥珀酸铁固体新剂型及其制备方法
CN112063676B (zh) * 2020-09-02 2021-11-12 杭州汉库医药科技有限公司 酪蛋白纯化方法和蛋白琥珀酸铁的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1150213B (it) 1982-03-02 1986-12-10 Italfarmaco Spa Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche
IT1222912B (it) 1987-10-14 1990-09-12 Italfarmaco Spa Derivati polipeptidici a elevato tenore di ferro e altamente solubili atti alla terapia marziale procedimenti di preparazione e loro forme farmaceutiche
IT1297022B1 (it) * 1997-12-24 1999-08-03 Chemi Spa Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono
ITMO20040200A1 (it) 2004-07-29 2004-10-29 Biofer Spa Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche.
JP2009518350A (ja) * 2005-12-06 2009-05-07 ヴィフォー・インターナショナル・アーゲー フェリ−スクシニルカゼインの製造方法
WO2007143088A2 (fr) * 2006-06-02 2007-12-13 Abbott Laboratories Ingrédient protéique ayant une qualité sensorielle améliorée et nutriments ayant un arôme amélioré contenant celui-ci
TWI346666B (en) * 2007-12-31 2011-08-11 Animal Technology Inst Taiwan Method for seperating casein from casein-contained solution

Also Published As

Publication number Publication date
RU2013103799A (ru) 2014-08-10
KR101701830B1 (ko) 2017-02-13
WO2012001712A1 (fr) 2012-01-05
KR20130136422A (ko) 2013-12-12
US20130102529A1 (en) 2013-04-25
SI2588488T1 (sl) 2017-07-31
CN107090011A (zh) 2017-08-25
BR112012032364B1 (pt) 2021-08-31
CN103025751A (zh) 2013-04-03
LT2588488T (lt) 2017-05-10
HUE032746T2 (en) 2017-10-30
EP2588488A1 (fr) 2013-05-08
AR122394A2 (es) 2022-09-07
BR112012032364A2 (pt) 2016-10-04
CN103025751B (zh) 2016-12-21
PL2588488T3 (pl) 2017-09-29
RU2533826C2 (ru) 2014-11-20
HRP20170541T1 (hr) 2017-06-16
MX346317B (es) 2017-03-15
DK2588488T3 (en) 2017-04-03
ES2628306T3 (es) 2017-08-02
MX2012014199A (es) 2013-05-06
RS55978B1 (sr) 2017-09-29
EP2588488B1 (fr) 2017-03-15
PT2588488T (pt) 2017-06-26
CY1119054T1 (el) 2018-01-10

Similar Documents

Publication Publication Date Title
MX2010013578A (es) Metodo y sistema para la recuperacion de metal de materiales reciclados procesados.
MX336731B (es) Composiciones y metodos para potenciar la actividad de proteasoma.
EA201491113A1 (ru) Экстракция молочной кислоты
IN2014MN02355A (fr)
MX2011013243A (es) Marcadores de riesgo para enfermedad cardiovascular.
EA201071178A1 (ru) Усовершенствованные способы гашения нежелательных побочных реакций при патогенной инактивации эритроцитов
MX2009003542A (es) Metodos y composiciones con opalescencia reducida.
MA34319B1 (fr) Caséinesuccinylate de fer (iii) et son procédé de préparation
FI20096347A7 (fi) Tehostettu metalliseosten saanti terässulasta käyttäen pelkistimillä doupattuja ydinlankoja
WO2012012712A3 (fr) Composés renforçant l'activité protéasome tricyclique
NZ723792A (en) Oxygen scavenging compositions
CH707538A8 (fr) Alliage d'or rose pour pièce d'horlogerie.
EA201171466A1 (ru) Композиция неслеживающейся соли, способ ее получения и использование
WO2012161460A3 (fr) Alliage d'aluminium et son procédé de fabrication
EP2563723A4 (fr) Procédé de traitement de l'eau
TR201820496T4 (tr) Magnezyum, saflaştırılmış magnezyum ve zirkonyum metal üretiminde safsızlıkların azaltılması için yöntemler.
WO2011078500A3 (fr) Fonte cgi et son procédé de fabrication
WO2012072977A8 (fr) Formulations de composé
MY171251A (en) Offshore structure
MX2014005399A (es) Metodos para tratar gota en sub-poblaciones de pacientes.
MY149706A (en) Method for producing aqueous ?-sulfo fatty acid alkyl ester salt solution
MX343359B (es) Rebar de alta resistencia.
PL1663195T3 (pl) Bromamina tauryny użyta do hamowania rozwoju bakterii i grzybów chorobotwórczych i w kompozycji przeciw drobnoustrojom
AR072152A1 (es) Metodos para preparar compuestos biciclicos de imidazol
FR3046062B1 (fr) Procede d'extraction d'ions metalliques des fibres keratiniques par application repetee d'une composition acide